Belvedere Trading LLC Acquires New Holdings in Enfusion, Inc. (NYSE:ENFN)

Belvedere Trading LLC bought a new position in shares of Enfusion, Inc. (NYSE:ENFN) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 12,041 shares of the company’s stock, valued at approximately $114,000.

A number of other institutional investors have also made changes to their positions in the stock. Harbor Capital Advisors Inc. lifted its stake in Enfusion by 12.4% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 11,887 shares of the company’s stock worth $113,000 after acquiring an additional 1,315 shares in the last quarter. 272 Capital LP lifted its position in shares of Enfusion by 1.5% during the second quarter. 272 Capital LP now owns 139,180 shares of the company’s stock worth $1,186,000 after purchasing an additional 2,000 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of Enfusion by 11.0% during the first quarter. California State Teachers Retirement System now owns 36,002 shares of the company’s stock worth $333,000 after purchasing an additional 3,556 shares in the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of Enfusion by 27.7% in the second quarter. The Manufacturers Life Insurance Company now owns 19,562 shares of the company’s stock valued at $167,000 after purchasing an additional 4,239 shares during the period. Finally, Allspring Global Investments Holdings LLC acquired a new position in shares of Enfusion in the first quarter valued at approximately $44,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.

Enfusion Stock Down 3.6 %

Enfusion stock opened at $8.72 on Tuesday. Enfusion, Inc. has a 52-week low of $7.52 and a 52-week high of $10.45. The firm has a market cap of $1.12 billion, a PE ratio of 218.00, a price-to-earnings-growth ratio of 2.47 and a beta of 0.93. The company’s 50 day moving average is $8.76 and its two-hundred day moving average is $8.84.

Enfusion (NYSE:ENFN) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.01). Enfusion had a net margin of 1.98% and a return on equity of 6.17%. The company had revenue of $49.46 million during the quarter, compared to analyst estimates of $50.27 million. On average, equities research analysts anticipate that Enfusion, Inc. will post 0.07 earnings per share for the current fiscal year.

About Enfusion

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.